Losmapimod oral tablet

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Losmapimod Safety and Efficacy in COVID-19NCT04511819Fulcrum TherapeuticsPhase 3Terminated2021-03-31Actual
Efficacy and Safety of Losmapimod in Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD)NCT04003974Fulcrum TherapeuticsPhase 2Completed2021-01-28Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.